Crowson A Neil, Magro Cynthia, Miller Arlo, Mihm Martin C
Department of Dermatology, University of Oklahoma and Regional Medical Laboratory, St. John Medical Center, Tulsa, OK 74114-4109, USA.
Semin Oncol. 2007 Dec;34(6):476-90. doi: 10.1053/j.seminoncol.2007.09.007.
The last two decades have seen spectacular advances in our understanding of the biology of melanoma and, in particular, have elucidated the mechanisms operative in disease initiation and progression. With respect to the former, the genetics of melanoma and in particular the impact of genetic defects on dysregulation of the cell cycle are key issues in malignant transformation and are a major focus of this review. With respect to the latter, consideration also is given to the acquisition of growth factor autonomy and the capacity for invasion and metastasis from the standpoint of cell adhesion, motility, and matrix digestion. These events have specific morphologic correlates that will be briefly addressed. Where relevant, we will address certain of the modern pharmacogenetic strategies that flow from these novel observations concerning melanoma biology.
在过去二十年里,我们对黑色素瘤生物学的理解取得了惊人进展,尤其是阐明了疾病发生和发展过程中的作用机制。关于前者,黑色素瘤的遗传学,特别是基因缺陷对细胞周期失调的影响,是恶性转化的关键问题,也是本综述的主要焦点。关于后者,还从细胞黏附、运动和基质消化的角度考虑了生长因子自主性的获得以及侵袭和转移能力。这些事件具有特定的形态学关联,将简要阐述。在相关情况下,我们将探讨基于这些关于黑色素瘤生物学的新发现而产生的某些现代药物遗传学策略。